Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2011-07-12
2011-07-12
Hartley, Michael G (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001110, C424S001250, C424S001650, C424S001730, C506S042000, C506S032000, C502S159000
Reexamination Certificate
active
07976824
ABSTRACT:
The invention relates to a compound of formula (I): wherein P1, P2, P3, and P4are each independently hydrogen or a protecting group; and n is an integer of from 2 to 20 and to the use of such compounds for the synthesis of18F-FDG.
REFERENCES:
patent: 02/055026 (2002-07-01), None
patent: 03/002157 (2003-01-01), None
Tumelty, et.al., “Traceless Solid-Phase Synthesis of Substituted Benzimidazoles via a Base-Cleavable Linker”, Organic Letters, 2001 vol. 3, No. 1 pp. 83-86.
PCT/GB2004/003287 Int'l Search Report dated Oct. 2004.
GB 0317920.7 Search Report dated Jan. 2004.
Brown Lynda Jane
Brown Richard Charles Downie
Jackson Alexander
Wadsworth Harry John
GE Healthcare Limited
Hartley Michael G
Schlientz Leah
LandOfFree
Production of 2-18F-2-deoxy-D-glucose via solid-phase synthesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production of 2-18F-2-deoxy-D-glucose via solid-phase synthesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of 2-18F-2-deoxy-D-glucose via solid-phase synthesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2702170